| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $488M | — | — | — | — |
| Op. Income | $128M | — | — | — | — |
| Gross Margin | 99.3% | — | — | — | — |
| Net Margin | 18.0% | — | — | — | — |
| EPS (Diluted) | $1.10 | — | — | — | — |
| Free Cash Flow | $330M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $488M |
| Cost of Revenue | $3M |
| GROSS PROFIT | $485M |
| R&D Expenses | $0 |
| Selling & Marketing | $308M |
| General & Administrative | $10M |
| SG&A Expenses | $318M |
| Other Expenses | $39M |
| Operating Expenses | $357M |
| Cost & Expenses | $360M |
| OPERATING INCOME | $128M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $10M |
| INCOME BEFORE TAX | $138M |
| Income Tax Expense | $39M |
| Net Income from Continuing Ops | $99M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $88M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $88M |
| D&A | $3M |
| EBIT | $138M |
| EBITDA | $141M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $488M |
| Cost of Revenue | $3M |
| GROSS PROFIT | $485M |
| R&D Expenses | $0 |
| Selling & Marketing | $308M |
| General & Administrative | $10M |
| SG&A Expenses | $318M |
| Other Expenses | $39M |
| Operating Expenses | $357M |
| Cost & Expenses | $360M |
| OPERATING INCOME | $128M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $10M |
| INCOME BEFORE TAX | $138M |
| Income Tax Expense | $39M |
| Net Income from Continuing Ops | $99M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $88M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $88M |
| D&A | $3M |
| EBIT | $138M |
| EBITDA | $141M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $88M |
| Depreciation & Amortization | $3M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $95M |
| Change in Working Capital | $152M |
| OPERATING CASH FLOW | $339M |
| Capital Expenditure | -$9M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$116M |
| Sales/Maturities of Investments | $116M |
| Other Investing Activities | -$733.0K |
| NET CASH FROM INVESTING | -$10M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$46M |
| Common Dividends Paid | -$53M |
| Other Financing Activities | -$288.0K |
| NET CASH FROM FINANCING | -$100M |
| FREE CASH FLOW | $330M |
| Net Change in Cash | $227M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $509M |
| Short-Term Investments | $0 |
| Net Receivables | $82M |
| Inventory | $0 |
| Other Current Assets | $30M |
| TOTAL CURRENT ASSETS | $620M |
| PP&E (Net) | $307M |
| Goodwill | $0 |
| Intangible Assets | $768.0K |
| Long-Term Investments | $369M |
| Tax Assets | $443M |
| Other Non-Current Assets | $73M |
| TOTAL NON-CURRENT ASSETS | $1.2B |
| TOTAL ASSETS | $1.8B |
| Account Payables | $44M |
| Short-Term Debt | $29M |
| Deferred Revenue | $9M |
| Other Current Liabilities | -$793M |
| TOTAL CURRENT LIABILITIES | $29M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $9M |
| Deferred Tax Liabilities | $72M |
| Other Non-Current Liabilities | $784M |
| TOTAL NON-CURRENT LIABILITIES | $1.1B |
| TOTAL LIABILITIES | $1.1B |
| Common Stock | $891.0K |
| Additional Paid-In Capital | $1.9B |
| Retained Earnings | -$801M |
| Treasury Stock | -$536M |
| Accum. Other Comp. Income | -$7M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $568M |
| Minority Interest | $112M |
| TOTAL EQUITY | $680M |
| TOTAL LIABILITIES & EQUITY | $1.8B |
| Total Debt | $267M |
| Net Debt | -$241M |
